Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 13-24 of 141
» View wsbtradio.com items only
    May 15, 2013 |Story| Reuters
  1. Bristol melanoma drug combo marks new advance in immunotherapy

    Reuters
    (For more stories on new cancer data, see ) By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance...

    Tags: Renal cell carcinoma, Oncology, Medical Specialization, Merck & Company Incorporated, Skin Cancer

  2. May 14, 2013 |Story| AP Broadcast
  3. India announces development of cheap vaccine against major cause of diarrhea deaths in kids

    Associated Press
    NEW DELHI (AP) — The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world. The Indian...

    Tags: Rotavirus, Diseases and Illnesses, U.S. Centers for Disease Control and Prevention, Vaccines, Disease Prevention

  4. Feb 10, 2013 |Story| Chicago Tribune
  5. Do soaps with triclosan do more harm than good?

    If co-workers and family members are coming down with infections this winter, you may be tempted to turn to an anti-bacterial soap for protection.
    If co-workers and family members are coming down with infections this winter, you may be tempted to turn to an anti-bacterial soap for protection. But some scientists are increasingly concerned that a common anti-bacterial ingredient called triclosan...

    Tags: Physical Fitness and Exercise, Teachers, American Medical Association, Consumers, Viral Diseases and Infections

  6. May 13, 2013 |Story| Reuters
  7. Wall St termina plano tras recientes máximos

    Reuters
    Por Caroline Valetkevitch NUEVA YORK (Reuters) - Las acciones cerraron planas el lunes en la bolsa de Nueva York, tomándose un respiro tras trepar a máximos históricos la semana pasada, pero la fortaleza del sector cuidado de la salud ayudó a que los...

    Tags: Stock Market, Financial Markets, S&P 500, Theravance Incorporated, Elan Corporation Plc

  8. Apr 21, 2013 |Story| Chicago Tribune
  9. Athletes only too happy to be 'lab rats'

    After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound.
    After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound. But the failed experimental drug, called GW501516, is making a comeback in another...

    Tags: Physical Fitness and Exercise, Lifestyle and Leisure, Consumers, Steroids, Salk Institute for Biological Studies

  10. May 13, 2013 |Story| Reuters
  11. Elan alcanza acuerdo por regalías de 1.000 mln dlrs con Theravance

    Reuters
    Por Padraic Halpin DUBLIN (Reuters) - Elan intensificó el lunes su intento por mantener su independencia al alcanzar un acuerdo de 1.000 millones de dólares para comprar el 21 por ciento de las regalías que la firma estadounidense Theravance recibe de...

    Tags: Theravance Incorporated, Elan Corporation Plc, Biogen Idec Incorporated

  12. May 13, 2013 |Story| Reuters
  13. US STOCKS-Futures dip after record high; retail sales on tap

    Reuters
    * Elan, Theravance reach royalties deal * Retail sales for April on tap * Futures off: Dow 40 pts, S&P 5.4 pts, Nasdaq 11.75 pts By Chuck Mikolajczak NEW YORK, May 13 (Reuters) - U.S. stock index futures dipped on Monday, indicating the S&P 500 may...

    Tags: NASDAQ, Sprint Nextel Corporation, Stock Market, Theravance Incorporated, S&P 500

  14. May 13, 2013 |Story| Reuters
  15. Late payment costs European companies 350 billion euros

    Reuters
    * European businesses forced to write off 3 pct of receivables * Late payment hitting southern Europe harder than the north * Business confidence down across Europe * European Union legislation not enough to help smaller firms By Clare Hutchison...

    Tags: European Union, Business Enterprises, Private Business Incorporated, Bankruptcy, Economy, Business and Finance

  16. May 13, 2013 |Story| Reuters
  17. Elan-Theravance deal a big boost for Baupost, Fidelity

    Reuters
    By Tim McLaughlin BOSTON, May 13 (Reuters) - Fidelity Investments and hedge fund Baupost Group LLC got a lift on Monday from their investment in Theravance Inc after the U.S.-based biopharmaceutical company agreed to a $1 billion royalty deal with...

    Tags: Warren Buffett, Theravance Incorporated, Elan Corporation Plc, Thomson Corporation

  18. May 12, 2013 |Story| Reuters
  19. UPDATE 1-Elan strikes $1 bln royalty deal with Theravance

    Reuters
    * Elan to acquire newly approved Breo as part of $1 bln deal * Irish drugmaker to announce further deals in due course * Looks to outmanoeuvre Royalty with second shareholder dividend By Padraic Halpin DUBLIN, May 13 (Reuters) - Elan stepped up its...

    Tags: COPD, Asthma, Multiple Sclerosis, Theravance Incorporated, Elan Corporation Plc

  20. May 9, 2013 |Story| Reuters
  21. PRESS DIGEST-New York Times business news - May 10

    Reuters
    May 10 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * The Bank of Japan's efforts to reinvigorate the nation's economy are showing...

    Tags: Viral Diseases and Infections, Human papillomavirus, Merck & Company Incorporated, The New York Times, Delta Air Lines

  22. May 9, 2013 |Story| Reuters
  23. Merck, Glaxo reducen precio de vacuna contra cáncer cervical para países pobres

    Reuters
    LONDRES (Reuters) - Las farmacéuticas Merck y GlaxoSmithKline redujeron el precio de las vacunas contra el cáncer de cuello de útero en un acuerdo que les permitirá venderlas a los países más pobres por menos de 5 dólares la dosis. El nuevo precio...

    Tags: Viral Diseases and Infections, Merck & Company Incorporated, HPV Vaccine

< Previous1  2  3 4 5 6 7 8 9 10 11-12Next >
Original site for GlaxoSmithKline PLC topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
GlaxoSmithKline PLC Photos
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC
Third grader Kira Lingle of Quakertown rolls up a strea...
(July 10, 2012)
Science in the Summer program
A bottle of Xenical, a weight-loss aid made by GlaxoSmi...
(May 9, 2012)
GlaxoSmithKline launches hostile tender offer for Human Genome Sciences